Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.70 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.70 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.70 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.70 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.68 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.67 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.67 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4415327 | 0.93 | SLC28A1 (0.67) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2444841 | 0.90 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL6053985 | 0.90 | SLC28A1 (0.74) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2724554 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2635506 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL24211446 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL15226209 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2552454 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL4948478 | 0.89 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL5443291 | 0.89 | SLC28A1 (0.72) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3133172-B1 | KIT FOR CODING GENOMIC MORSE | PASTEUR INSTITUT (FR) | 2019-07-31 | — | — | EP | disclosed |
| US-20190114464-A1 | METHOD OF CURVILINEAR SIGNAL DETECTION AND ANALYSIS AND ASSOCIATED PLATFORM | GENOMIC VISION (FR) | 2019-04-18 | — | — | US | disclosed |
| US-20190073444-A1 | METHOD FOR ANALYZING A SEQUENCE OF TARGET REGIONS AND DETECT ANOMALIES | GENOMIC VISION (FR) | 2019-03-07 | — | — | US | disclosed |
| EP-3427183-A1 | METHOD OF CURVILINEAR SIGNAL DETECTION AND ANALYSIS AND ASSOCIATED PLATFORM | Genomic Vision (FR) | 2019-01-16 | — | — | EP | disclosed |
| EP-3427171-A1 | METHOD FOR ANALYZING A SEQUENCE OF TARGET REGIONS AND DETECT ANOMALIES | Genomic Vision (FR) | 2019-01-16 | — | — | EP | disclosed |
| EP-2175037-B1 | Method for analyzing D4Z4 tandem repeat arrays of nucleic acid and kit therefore | GENOMIC VISION (FR) | 2017-10-11 | — | — | EP | disclosed |
| EP-3133172-A1 | GENOMIC MORSE CODE | Institut Pasteur (FR) | 2017-02-22 | — | — | EP | disclosed |
| EP-2059609-B1 | GENOMIC MORSE CODE | PASTEUR INSTITUT (FR) | 2016-08-31 | — | — | EP | disclosed |
| US-9422607-B2 | Method for analyzing D4Z4 tandem repeat arrays of nucleic acid and kit therefore | UNIVERSITE D'AIX-MARSEILLE (FR) | 2016-08-23 | — | — | US | disclosed |
| WO-2014086480-A1 | LIGNAN COMPOSITIONS | ALPINIA LAUDANUM INSTITUTE OF PHYTOPHARMACEUTICAL SCIENCES AG (CH) | 2014-06-12 | — | — | WO | disclosed |
| WO-2010035140-A1 | METHOD FOR ANALYZING D4Z4 TANDEM REPEAT ARRAYS OF NUCLEIC ACID AND KIT THEREFORE | GENOMIC VISION (FR) | 2010-04-01 | — | — | WO | disclosed |
| US-20100041036-A1 | GENOMIC MORSE CODE | INSTITUT PASTEUR (FR) | 2010-02-18 | — | — | US | disclosed |
| EP-2059609-A1 | GENOMIC MORSE CODE | Institut Pasteur (FR) | 2009-05-20 | — | — | EP | disclosed |
| US-20080064114-A1 | Genomic morse code | INSTITUT PASTEUR | 2008-03-13 | — | — | US | disclosed |
| WO-2008028931-A1 | GENOMIC MORSE CODE | INSTITUT PASTEUR (FR) | 2008-03-13 | — | — | WO | disclosed |
| US-6339172-B1 | REACTING LABELED NUCLEIC ACID PROBE WITH AN OBJECTIVE SUBSTANCE ON A BIOLOGICAL SAMPLE SELECTED FROM TISSUE, CELL AND CHROMOSOME ADDING HEAVY METAL AND ASSAYING FLUORESCENCE OF COMPLEX FORMED | Matsumoto, Kazuko (JP) | 2002-01-15 | — | — | US | disclosed |
| EP-0602211-B1 | USE OF GROWTH FACTOR IGF-II FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | PHARMACIA & UPJOHN AB (SE) | 1999-08-25 | — | — | EP | disclosed |
| US-5482926-A | NUTRITIONAL OR GASTROINTESTINAL DISORDERS; PROMOTING NEONATAL GROWTH | PHARMACIA AB (SE) | 1996-01-09 | — | — | US | disclosed |
| EP-0602211-A1 | USE OF GROWTH FACTOR IGF-II | Pharmacia AB (reg.number 556131-9608) (SE) | 1994-06-22 | — | — | EP | disclosed |
| WO-1993025227-A1 | USE OF GROWTH FACTOR IGF-II | KABI PHARMACIA AB (SE) | 1993-12-23 | — | — | WO | disclosed |